Joining VeloClub not only supports the work we do, there are some fantastic benefits:
by Shane Stokes
October 21, 2017
Fernando Gaviria doubles up at the Tour of Guangxi, extends overall lead; Welsford wins again in Gippsland, Moran best in women’s race; Broeckx continuing to amaze in recovery from brain injury; Doctor under investigation in Sky scandal resigns amid talk of poor health; Young French rider killed in accident at Tour of New Caledonia; Bardiani-CSF team may escape suspension despite a third rider testing positive; UCI President: One-day La Course is ‘not enough’; Simon Yates on 2018 Tour route: ‘I would prefer the climbs to arrive earlier’; Victoria sets up Office for Women in Sport, cyclist Bridie O’Donnell to head; Video: Taiwan KOM Challenge from the view of Cadel Evans; Video: Contador gets warm welcome from fans in Japan
Michael Bresciani joined the Bardiani-CSF team after Nicola Ruffoni (pictured) and Stefano Pirazzi tested positive.
Already suspended between June 14 and July 14 of this year after Nicola Ruffoni and Stefano Pirazzi tested positive for GH-Releasing Peptides, the Bardiani-CSF team is under pressure following a third positive test.
The 22-year-old Italian Michael Bresciani tested positive for the diuretic furosemide. It is banned under WADA’s rules as it can mask more significant products. Ironically, he was brought into the team on June 1 in order to replace the two fired riders. According to La Gazzetta dello Sport, he was tested at the Italian national championships and the sample revealed the banned product.
Bresciani has, unsurprisingly, claimed innocence. Rather than admitting using the substance, he claimed his ingestion was accident. “I know I have not done anything wrong. The problem is that my mother takes Lasix at meals. In splitting the tablet, it must have ended up through force somewhere in my plate. The UCI is investigating the case and has not yet issued the verdict, but I do not think I can be punished beyond [the penalty for] neglect.” Lasix is used to treat fluid retention and high blood pressure.
Bresciani’s excuse is similar to that of the Italian tennis player Sara Errani. In August it was announced that she had tested positive for Letrozole and would be suspended for two months. The substance is used for the treatment of hormonally-responsive breast cancer after surgery. She claimed that it got into her system after she accidentally consumed her mother’s medication Femara when visiting her family.
However although UCI rule 7.12.2 suggests that a third positive in a 12 month period by a team can lead to a ban of between 15 days and 12 months, Bardiani-CSF seems not to be affected as the rule only pertains to non-specified substances. Furosemide is in the latter category.